Working Note: Sammaan Capital

Knowledge Snapshot

This file is internal issuer coverage memory. It records objective context so that a new research agent with zero prior knowledge can continue coverage without repeating already confirmed checks. Detailed figures are stored in data/sammaan_capital_key_metrics_20260521.json; this file keeps only the credit-relevant context and trends.

Last updated: 2026-08-20

Issuer Overview

• Sammaan Capital Limited is the former Indiabulls Housing Finance Limited and uses the debt ticker IHFLIN.
• It is an Indian non-bank financial company / housing finance-oriented lender with core businesses in housing loans, loans against property, secured business finance, and commercial real estate-related lending.
• Company materials describe Sammaan Capital as an Upper Layer NBFC designated by the RBI, so the credit analysis should focus on loan asset quality, capital, liquidity, market funding, co-lending / direct assignment, regulatory capital, and sponsor support rather than a deposit franchise.

Core Credit View

• Sammaan Capital should be treated as a sponsor-supported reconstruction NBFC after a legacy loan-book clean-up, not as a fully seasoned high-quality NBFC.
• The March 31, 2026 IHC / Avenir promoter transaction materially improved the support story through capital injection, expected governance involvement, and rating-agency recognition.
• Expected IHC support is a major credit factor, but no explicit guarantee, keepwell, or debt payment obligation from IHC / Avenir has been confirmed.
• FY2026 results included a very large loss and reduced equity, so the credit profile still depends on FY2027 evidence of normal profitability, asset-quality stability, and funding access.
• Q1 FY2027 returned to consolidated PAT of Rs.243.30 crore. The official filing reported standalone CRAR of 20.06%, LCR of 127%, GNPA of 0.22% and NNPA of 0.17% at 30 June 2026. These are positive reported indicators, but the detailed ALM, liquidity composition, ECL and asset-quality bridge remain necessary to assess durability.

Business and Franchise View

• The company-defined end-FY2026 restart AUM was Rs 53,160 crore, split mainly among housing finance, secured business loans / LAP, commercial real estate and project-related exposure, and a small other-loans bucket.
• Housing finance is the most defensive part of the book, while commercial real estate and project-related exposure remain important risk areas because they overlap with the legacy stress history.
• The company targets a much larger product and branch footprint by FY2029. That plan can support franchise recovery but also increases underwriting, systems, collections, staffing, and ALM execution risk.
• The post-clean-up book has a short track record. The company's zero GNPA / NNPA statement applies to a company-defined restart AUM after clean-up and should be tested against FY2027 performance.

Capital Structure and Structural Points

• Avenir Investment RSC Limited, affiliated with International Holding Company PJSC, became promoter on March 31, 2026.
• Company materials state current IHC / Avenir ownership at 28.5% and ownership after warrant conversion at 43.5%; CRISIL separately cites 41.2% fully diluted ownership and potential ownership of 63.4% including an open offer.
• The initial capital received was Rs 5,652 crore, with Rs 3,198 crore of remaining warrant consideration expected.
• End-FY2026 equity was Rs 18,991 crore and company-disclosed gearing was 2.7x. Capital headroom requires confirmation through CRAR, Tier 1, Stage-wise loan data, and risk-weighted assets in the FY2026 annual report.
• Individual NCDs, retail bonds, subordinated debt, CP, and any foreign-currency bonds may differ materially in collateral, ranking, covenants, change-of-control terms, and guarantees.

Liquidity and Funding View

• End-FY2026 cash and cash equivalents, other bank balances, and investments were large and support near-term liquidity.
• Funding remains dependent on debt securities, other borrowings, subordinated liabilities, bank lines, securitisation / direct assignment, and market confidence.
• Domestic rating upgrades to AA+ / Stable from CRISIL, CARE, and ICRA support funding access, but the detailed CARE and ICRA rationales and rated debt lists remain to be checked.
• The board approved raising up to Rs 10,000 crore through debt securities in domestic and overseas markets. Actual tenor, collateral, currency, pricing, and use of proceeds are important confirmation items.
• The Q1 FY2027 filing disclosed a US$45m buyback of the 7.5% senior secured social bonds due 2030 during the quarter, a subsequent US$18m buyback of the 9.70% senior secured social bonds due 2027, and a Rs.1,400 crore secured listed-NCD allotment in July. It also reported certain covenant breaches under other borrowing arrangements; the affected facilities, waiver/cure status and implications beyond the specified covered debentures remain unconfirmed.

Credit Strengths

• Strong sponsor-support expectation after IHC / Avenir became promoter.
• Large capital injection and pending warrant consideration.
• Domestic AA+ / Stable rating recognition from multiple Indian rating agencies.
• Substantial end-FY2026 liquidity and investments.
• Potentially cleaner starting point after large FY2026 impairment and exceptional-loss recognition.
• Secured lending orientation, with housing finance as the largest product bucket.

Credit Weaknesses

• FY2026 full-year loss and Q4 FY2026 clean-up materially reduced equity.
• Limited post-restart operating track record.
• Commercial real estate and project-related lending remains a significant risk bucket.
• Market funding dependence is structurally higher than for banks with deposit franchises.
• Explicit sponsor guarantee, keepwell, ALM details, CRAR / Tier 1, unused committed lines, and detailed bond protections remain unconfirmed.

Rating Watchpoints

• Changes in IHC / Avenir ownership, warrant conversion, board control, or stated support stance.
• FY2027 return to profit, normalisation of credit costs, and absence of additional exceptional losses.
• GNPA, NNPA, Stage 2 / Stage 3 loans, ECL movement, write-offs, and recoveries after the restart.
• Execution terms for the Rs 10,000 crore debt-raising programme.
• CRISIL, CARE, ICRA, and any foreign-currency rating updates after the FY2026 annual report and Q1 FY2027 results.

Recurring Analytical Cautions

• Do not treat the company-defined restart AUM or zero GNPA / NNPA presentation as proof that future credit losses are eliminated.
• Do not equate IHC support expectations with a legal debt guarantee.
• Distinguish consolidated issuer credit from the legal terms and ranking of each bond.
• Interpret FY2026 losses as both evidence of legacy clean-up and a real capital reduction.
• Avoid comparing domestic AA+ ratings directly with global-scale ratings without adjusting for rating scale, sovereign, currency, and legal-structure risks.

Reliable Core Sources

• Sammaan Capital FY2026 earnings update dated May 20, 2026.
• Sammaan Capital March 31, 2026 IHC transaction press release.
• Sammaan Capital corporate announcements and financial-results pages.
• Sammaan Capital FY2025 annual report and Q3 FY2026 press release for background.
• CRISIL rating rationale dated April 9, 2026; CARE and ICRA public rating updates in May 2026.
• Internal structured metrics file: data/sammaan_capital_key_metrics_20260521.json.

Issuer Notes

This file is internal issuer coverage memory for research and writing judgment. It is not a change log. Detailed figures are stored in data/sammaan_capital_key_metrics_20260521.json; this file keeps monitoring items, unresolved questions, analytical cautions, and writing cautions.

Last updated: 2026-08-20

Ongoing Follow-Up Items

• Test the FY2027 quarterly results against the company's restart story: AUM growth, credit costs, delinquencies, collection performance, finance costs, and profitability.
• Monitor whether additional losses, ECL charges, recoveries, write-offs, collateral value changes, or asset-sale losses continue after the FY2026 legacy clean-up.
• Track whether the remaining Rs 3,198 crore warrant consideration is paid, how IHC / Avenir ownership changes, and whether the sponsor's management involvement deepens.
• Check liquidity through cash, bank balances, investments, committed / uncommitted lines, short-term debt, CP exposure, and ALM maturity buckets.
• Follow execution of the approved debt-raising programme of up to Rs 10,000 crore, including tenor, currency, fixed / floating rate, collateral, subordination, and use of proceeds.
• Watch domestic rating-agency follow-up after the FY2026 annual report and Q1 FY2027 results.
• Obtain the affected-facility list, breached metrics, lender waivers or consents, cure timetable, pricing/availability impact and any recurrence risk for the covenant breaches disclosed in the Q1 FY2027 asset-cover certificate.

Unresolved Issues and Items to Check Next Time

• FY2026 annual report notes, especially exceptional loss components, ECL movement, Stage-wise loans, write-offs, collateral, tax effects, and differences between standalone and consolidated figures.
• CRAR, Tier 1, risk-weighted assets, regulatory constraints under RBI / NHB rules, and capital headroom after warrant conversion.
• Detailed ALM, maturity walls, unused committed facilities, CP ratio, liquid-investment quality, and foreign-currency hedging.
• Full CARE and ICRA rating rationales, rating sensitivities, and rated-debt lists.
• Individual bond documentation for NCDs, retail bonds, subordinated debt, CP, and any foreign-currency debt, including collateral cover, negative lien, cross default, change of control, put rights, coupon step-up, and guarantee language.
• Whether any IHC / Avenir guarantee, keepwell, letter of comfort, liquidity support agreement, or other legally enforceable sponsor support exists. Treat it as unconfirmed until the instrument documents prove it.
• Terms, pricing, investor base, security, maturity and cross-default provisions of the Rs.1,400 crore secured listed-NCD allotment reported in July 2026; do not infer broad refinancing capacity from the completed transaction alone.

Analytical Cautions

• The issuer is a sponsor-supported reconstruction NBFC. Do not present it as a normalised high-quality NBFC until FY2027 earnings, asset quality, and funding performance confirm the restart.
• The FY2026 loss is not a simple recurring run rate, but it was still a real reduction in equity and capital flexibility.
• Commercial real estate and project-related exposure needs extra caution because it can be concentrated, collateral-dependent, and linked to past stress areas.
• Company-defined AUM, accounting loans, CRISIL-referenced AUM, and any securitised / assigned balances may use different scopes. Reconcile definitions before using trend language.
• Domestic AA+ ratings support Indian funding access but do not remove issuer-specific recovery, legal-structure, currency, and sponsor-support questions.
• The Q1 FY2027 reported CRAR/LCR and low GNPA/NNPA are positive point-in-time indicators, not proof that capital, liquidity or asset quality is durable. Keep the absence of a complete ALM, liquidity-composition, ECL and Stage-migration bridge explicit.

Report Wording Cautions

• Avoid wording that implies IHC guarantees Sammaan Capital debt unless a specific bond or support document confirms it.
• When referring to zero GNPA / NNPA, say it is the company's post-clean-up restart-AUM presentation, not proof that losses cannot arise.
• Avoid describing the Q4 FY2026 clean-up as purely positive; pair the potential reset benefit with the capital erosion.
• Separate company statements, rating-agency views, and Codex analytical conclusions.
• For any global or foreign-currency bond discussion, do not translate domestic AA+ ratings into global investment-grade language without explicit rating evidence.

Follow-Up on Management Strategy, Investment Plans, and Financial Policy

• Confirm whether growth targets for products and branches are accompanied by risk-management capacity, systems, staffing, and collections infrastructure.
• Monitor whether management prioritises profitable secured growth, asset-quality stabilisation, and funding diversification rather than rapid AUM expansion alone.
• Check whether the debt-raising programme lengthens maturities and diversifies funding or simply increases short-tenor market dependence.
• Track dividend policy, capital retention, and risk-asset growth once profitability resumes.

Items to Check for Ratings and Bond Investors

• CRISIL, CARE, ICRA, and any additional rating updates after FY2026 annual report and Q1 FY2027 results.
• Rating sensitivities around IHC ownership / support, GNPA, RoMA, funding access, and capitalisation.
• Rated-debt instrument lists and whether each rating maps to senior secured, senior unsecured, subordinated, CP, retail, or foreign-currency debt.
• Offering circulars, debenture trust deeds, term sheets, security cover certificates, and covenant compliance certificates for investable instruments.
• Market evidence for funding improvement, including actual issuance spreads, tenors, investor base, and any decline in funding costs.